Semireplication-competent vesicular stomatitis virus as a novel platform for oncolytic virotherapy

Among oncolytic viruses, the vesicular stomatitis virus (VSV) is especially potent and a highly promising agent for the treatment of cancer. But, even though effective against multiple tumor entities in preclinical animal models, replication-competent VSV exhibits inherent neurovirulence, which has...

Descripción completa

Detalles Bibliográficos
Autores principales: Muik, Alexander, Dold, Catherine, Geiß, Yvonne, Volk, Andreas, Werbizki, Marina, Dietrich, Ursula, von Laer, Dorothee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3396339/
https://www.ncbi.nlm.nih.gov/pubmed/22286341
http://dx.doi.org/10.1007/s00109-012-0863-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3396339/
https://www.ncbi.nlm.nih.gov/pubmed/22286341
http://dx.doi.org/10.1007/s00109-012-0863-6

Ejemplares similares